KIMBERLY DIAZ: Open Payments
NPI 1659721645 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 18 payments from 9 companies in 2025. Trend: 2023 $2,307 · 2024 $1,725 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $145 |
| Amgen Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $45 |
| PFIZER INC. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Abbott Laboratories | 1 | $20 |
| AGEPHA Pharma FZ LLC | 1 | $20 |
| Corcept Therapeutics | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: LEQVIO, EVKEEZA, REPATHA, PREVNAR 20, JARDIANCE, MOUNJARO, EVENITY, FREESTYLE LIBRE 3.
Industry payments across FL — which companies pay providers there.
